![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, February 13, 2024 1:33:55 PM
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173806573
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173782405
I think the recall of our loaned shares could be executed now.
But I don't think it will be. I think the recall will come with news that Humanigen could own between 89-92% of all Outstanding Shares. That degree of control has been long established.
And then, we get to new developments, potentially in regards to regulatory approval for CMML, with a possible PRV. Or news about partnerships, such as with Novavax, perhaps with an Advanced Purchase Agreement for the lenz/vaccine compound, and details about our Tera-Immune acquisition, or detail about a licensing agreement with Gracell. There's so much explosive potential! I'm looking forward to seeing it all!
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM